Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Tarsus Pharmaceuticals Inc shares valued at $318,699 were sold by Azamian Bobak R. on Mar 18 ’24. At $30.60 per share, Azamian Bobak R. sold 10,415 shares. The insider’s holdings dropped to 26,456 shares worth approximately $0.95 million following the completion of this transaction.
Also, Neervannan Seshadri sold 4,879 shares, netting a total of over 149,297 in proceeds. Following the sale of shares at $30.60 each, the insider now holds 64,767 shares.
Before that, Mottiwala Aziz had sold 4,766 shares from its account. In a trade valued at $145,840, the Chief Commercial Officer traded Tarsus Pharmaceuticals Inc shares for $30.60 each. Upon closing the transaction, the insider’s holdings decreased to 4,766 shares, worth approximately $1.94 million.
As published in their initiating research note from Goldman on November 20, 2023, Tarsus Pharmaceuticals Inc [TARS] has been a Neutral and the price target has been revised to $19. Analysts at William Blair started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid July. As of May 18, 2023, Guggenheim has initiated its “Buy” rating for TARS. Earlier on August 01, 2022, Barclays initiated its rating. Their recommendation was “an Overweight” for TARS stock.
Analyzing TARS Stock Performance
Over the course of the year, Tarsus Pharmaceuticals Inc shares have jumped approximately 77.19%. Shares of the company reached a 52-week high of $40.40 on 02/28/24 and a 52-week low of $18.99 on 01/05/24. A 50-day SMA is recorded $32.85, while a 200-day SMA reached $21.66. Nevertheless, trading volume fell to 0.47 million shares from 0.46 million shares the previous day.
Support And Resistance Levels for Tarsus Pharmaceuticals Inc (TARS)
According to the 24-hour chart, there is a support level at 35.17, which, if violated, would cause prices to drop to 34.47. In the upper region, resistance lies at 36.53. The next price resistance is at 37.18. RSI (Relative Strength Index) is 58.76 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.75, which suggests the price will decrease in the coming days. Percent R is at 32.96%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Tarsus Pharmaceuticals Inc subject to short interest?
Stocks of Tarsus Pharmaceuticals Inc saw a sharp rise in short interest on Mar 15, 2024 jumping by 1.54 million shares to 7.2 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 5.66 million shares. A jump of 21.39% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.37 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.37.
Which companies own the most shares of Tarsus Pharmaceuticals Inc (TARS)?
On December 21, 2021, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $40.
